Publication

Vanderbilt DB, Ho Q-A, Goyal U, Bell RC, Klein RR, Yi SK. 2018. HPV-related nasopharyngeal and cervical cancer in a married couple in North America. Pract Radiat Oncol. 8:e1-e5. doi:10.1016/j.prro.2017.09.003.

Casillas AL, Toth RK, Sainz AG, Singh N, Desai AA, Kraft AS, Warfel NA. 2018. Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents. Clin Cancer Res. 24:169–180. doi:10.1158/1078-0432.CCR-17-1318.

Liptak C, Mahmoud MM, Eckenroth BE, Moreno MV, East K, Alnajjar KS, Huang J, Towle-Weicksel JB, Doublié S, Loria JP, et al. 2018. I260Q DNA polymerase β highlights precatalytic conformational rearrangements critical for fidelity. Nucleic Acids Res. 46:10740–10756. doi:10.1093/nar/gky825.

Chipollini J, Azizi M, Peyton CC, Tang DH, Dhillon J, Spiess PE. 2018. Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma. J Kidney Cancer VHL. 5:6–13. doi:10.15586/jkcvhl.2018.107.

Fang K, Dong G, Wang H, He S, Wu S, Wang W, Sheng C. 2018. Improving the Potency of Cancer Immunotherapy by Dual Targeting of IDO1 and DNA. ChemMedChem. 13:30–36. doi:10.1002/cmdc.201700666.

Patil PD, Sultan S, Hahn MF, Biswas Roy S, Ross MD, Abdelrazek H, Bremner RM, Thawani N, Walia R, Panchabhai TS. 2018. Incidental extensive adenocarcinoma in lungs explanted from a transplant recipient with an idiopathic pulmonary fibrosis flare-up: A clinical dilemma. Respir Med Case Rep. 25:45–48. doi:10.1016/j.rmcr.2018.06.005.

Singh P, Jenkins LM, Horst B, Alers V, Pradhan S, Kaur P, Srivastava T, Hempel N, Győrffy B, Broude EV, et al. 2018. Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis. Cancer Res. 78:2978–2989. doi:10.1158/0008-5472.CAN-17-2316.

Schembre SM, Liao Y, Robertson MC, Dunton GF, Kerr J, Haffey ME, Burnett T, Basen-Engquist K, Hicklen RS. 2018. Just-in-Time Feedback in Diet and Physical Activity Interventions: Systematic Review and Practical Design Framework. J Med Internet Res. 20:e106. doi:10.2196/jmir.8701.

Bauer PV, Duca FA, Waise TMZ, Dranse HJ, Rasmussen BA, Puri A, Rasti M, O’Brien CA, Lam TKT. 2018. Lactobacillus gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid-Sensing Pathway Regulating Whole-Body Glucose Homeostasis. Cell Metab. 27:572–587.e6. doi:10.1016/j.cmet.2018.01.013.

Persky DO. 2018. Limited-stage DLBCL: it’s patient selection. Blood. 131:155–156. doi:10.1182/blood-2017-11-813915.

Lee DD, Croome KP, Musto KR, Melendez J, Tranesh G, Nakhleh R, Taner CB, Nguyen JH, Patel T, Harnois DM. 2018. Liver transplantation for intrahepatic cholangiocarcinoma. Liver Transpl. 24:634–644. doi:10.1002/lt.25052.

Lam WY, Jash A, Yao C-H, D’Souza L, Wong R, Nunley RM, Meares GP, Patti GJ, Bhattacharya D. 2018. Metabolic and Transcriptional Modules Independently Diversify Plasma Cell Lifespan and Function. Cell Rep. 24:2479–2492.e6. doi:10.1016/j.celrep.2018.07.084.

Bauer PV, Duca FA, Waise TMZ, Rasmussen BA, Abraham MA, Dranse HJ, Puri A, O’Brien CA, Lam TKT. 2018. Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway. Cell Metab. 27:101–117.e5. doi:10.1016/j.cmet.2017.09.019.

Xie L, Zhang L, Wang C, Wang X, Xu Y-M, Yu H, Wu P, Li S, Han L, Gunatilaka AAL, et al. 2018. Methylglucosylation of aromatic amino and phenolic moieties of drug-like biosynthons by combinatorial biosynthesis. Proc Natl Acad Sci U S A. 115:E4980-E4989. doi:10.1073/pnas.1716046115.

Harrison CA, Laubitz D, Ohland CL, Midura-Kiela MT, Patil K, Besselsen DG, Jamwal DR, Jobin C, Ghishan FK, Kiela PR. 2018. Microbial dysbiosis associated with impaired intestinal Na/H exchange accelerates and exacerbates colitis in ex-germ free mice. Mucosal Immunol. 11:1329–1341. doi:10.1038/s41385-018-0035-2.

Bapat A, Keita N, Martelly W, Kang P, Seet C, Jacobsen JR, Stoilov P, Hu C, Crooks GM, Sharma S. 2018. Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2-M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells. Stem Cells. 36:1663–1675. doi:10.1002/stem.2885.

Kelly KR, Espitia CM, Zhao W, Wu K, Visconte V, Anwer F, Calton CM, Carew JS, Nawrocki ST. 2018. Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy. Leukemia. 32:230–233. doi:10.1038/leu.2017.272.

Hadinger KP, Marshalek JP, Sheeran PS, Dayton PA, Matsunaga TO. 2018. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells. Ultrasound Med Biol. 44:2728–2738. doi:10.1016/j.ultrasmedbio.2018.08.003.

Sun V, Ercolano E, McCorkle R, Grant M, Wendel CS, Tallman NJ, Passero F, Raza S, Cidav Z, Holcomb M, et al. 2018. Ostomy telehealth for cancer survivors: Design of the Ostomy Self-management Training (OSMT) randomized trial. Contemp Clin Trials. 64:167–172. doi:10.1016/j.cct.2017.10.008.

Chipollini J, Necchi A, Spiess PE. 2018. Outcomes for Patients with Node-positive Penile Cancer: Impact of Perioperative Systemic Therapies and the Importance of Surgical Intervention. Eur Urol. 74:241–242. doi:10.1016/j.eururo.2018.04.025.

Migden MR, Rischin D, Schmults CD, Guminski A, Hauschild A, Lewis KD, Chung CH, Hernandez-Aya L, Lim AM, Chang ALS, et al. 2018. PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 379:341–351. doi:10.1056/NEJMoa1805131.

Famoso JM, Laughlin B, McBride A, Gonzalez VJ. 2018. Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapy. Adv Radiat Oncol. 3:19–24. doi:10.1016/j.adro.2017.09.004.

Huberty J, Eckert R, Larkey L, Gowin K, Mitchell J, Mesa R. 2018. Perceptions of Myeloproliferative Neoplasm Patients Participating in an Online Yoga Intervention: A Qualitative Study. Integr Cancer Ther. 17:1150–1162. doi:10.1177/1534735418808595.

Blohm-Mangone K, Burkett NB, Tahsin S, Myrdal PB, Aodah A, Ho B, Janda J, McComas M, Saboda K, Roe DJ, et al. 2018. Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice. Cancer Prev Res (Phila). 11:265–278. doi:10.1158/1940-6207.CAPR-17-0349.

Javle M, Lowery M, Shroff RT, Weiss KH, Springfeld C, Borad MJ, Ramanathan RK, Goyal L, Sadeghi S, Macarulla T, et al. 2018. Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma. J Clin Oncol. 36:276–282. doi:10.1200/JCO.2017.75.5009.